BACKGROUND: Major hepatectomy with extrahepatic bile duct resection for perihilar cholangiocarcinoma remains a highly morbid procedure. The association between preoperative sarcopenia and postoperative morbidity/mortality has been reported for various types of surgeries. The objective was to analyze the relationship between preoperative sarcopenia and postoperative morbidity/mortality in patients who underwent major hepatectomy with extrahepatic bile duct resection. METHODS: This study included 256 patients who underwent major hepatectomy with extrahepatic bile duct resection from 2008 to 2014. Preoperative sarcopenia was assessed by a measurement of the total psoas muscle area (TPA). The measured TPA was normalized by height. Preoperative sarcopenia was defined as the presence of a normalized TPA in the lowest sex-specific tertile. RESULTS: A total of 54 males and 31 females were determined to have preoperative sarcopenia. The length of the postoperative hospital stay for patients with sarcopenia was significantly longer than for those without sarcopenia (39 vs 30 days, p < 0.001). Patients with sarcopenia experienced a significantly higher rate of liver failure (ISGLS grade ≥ B) (33 vs 16%), major complications with Clavien grade ≥ 3 (54 vs 37%), and intra-abdominal abscess (29 vs 18%) than those without sarcopenia (all p < 0.05). After a multivariate analysis, low normalized TPA (male <567 mm(2)/m(2); female <395 mm(2)/m(2)) was identified as an independent risk factor for the development of liver failure (odds ratio 2.46). CONCLUSIONS: This study demonstrated that preoperative sarcopenia increased the morbidity rate including the rate of liver failure, in patients who underwent major hepatectomy with extrahepatic bile duct resection.
BACKGROUND: Major hepatectomy with extrahepatic bile duct resection for perihilar cholangiocarcinoma remains a highly morbid procedure. The association between preoperative sarcopenia and postoperative morbidity/mortality has been reported for various types of surgeries. The objective was to analyze the relationship between preoperative sarcopenia and postoperative morbidity/mortality in patients who underwent major hepatectomy with extrahepatic bile duct resection. METHODS: This study included 256 patients who underwent major hepatectomy with extrahepatic bile duct resection from 2008 to 2014. Preoperative sarcopenia was assessed by a measurement of the total psoas muscle area (TPA). The measured TPA was normalized by height. Preoperative sarcopenia was defined as the presence of a normalized TPA in the lowest sex-specific tertile. RESULTS: A total of 54 males and 31 females were determined to have preoperative sarcopenia. The length of the postoperative hospital stay for patients with sarcopenia was significantly longer than for those without sarcopenia (39 vs 30 days, p < 0.001). Patients with sarcopenia experienced a significantly higher rate of liver failure (ISGLS grade ≥ B) (33 vs 16%), major complications with Clavien grade ≥ 3 (54 vs 37%), and intra-abdominal abscess (29 vs 18%) than those without sarcopenia (all p < 0.05). After a multivariate analysis, low normalized TPA (male <567 mm(2)/m(2); female <395 mm(2)/m(2)) was identified as an independent risk factor for the development of liver failure (odds ratio 2.46). CONCLUSIONS: This study demonstrated that preoperative sarcopenia increased the morbidity rate including the rate of liver failure, in patients who underwent major hepatectomy with extrahepatic bile duct resection.
Authors: Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz Journal: Surgery Date: 2011-01-14 Impact factor: 3.982
Authors: Peter D Peng; Mark G van Vledder; Susan Tsai; Mechteld C de Jong; Martin Makary; Julie Ng; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Michael A Choti; Ihab Kamel; Timothy M Pawlik Journal: HPB (Oxford) Date: 2011-03-29 Impact factor: 3.647
Authors: J V Reynolds; C O'Farrelly; C Feighery; P Murchan; N Leonard; G Fulton; C O'Morain; F B Keane; W A Tanner Journal: Br J Surg Date: 1996-09 Impact factor: 6.939
Authors: Peter Peng; Omar Hyder; Amin Firoozmand; Peter Kneuertz; Richard D Schulick; Donghang Huang; Martin Makary; Kenzo Hirose; Barish Edil; Michael A Choti; Joseph Herman; John L Cameron; Christopher L Wolfgang; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2012-06-13 Impact factor: 3.452
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Angela B Smith; Allison M Deal; Hyeon Yu; Brian Boyd; Jonathan Matthews; Eric M Wallen; Raj S Pruthi; Michael E Woods; Hyman Muss; Matthew E Nielsen Journal: J Urol Date: 2014-01-11 Impact factor: 7.450
Authors: Marina Mourtzakis; Carla M M Prado; Jessica R Lieffers; Tony Reiman; Linda J McCargar; Vickie E Baracos Journal: Appl Physiol Nutr Metab Date: 2008-10 Impact factor: 2.665
Authors: Michael S Lustgarten; Lori Lyn Price; Angela Chale; Edward M Phillips; Roger A Fielding Journal: J Gerontol A Biol Sci Med Sci Date: 2013-10-01 Impact factor: 6.053